Peptide record

TPDB06202

Antibacterial Anticancer Hemolysis Toxicity standard
11 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB06202
Antibacterial Anticancer Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 Peptipedia ACP740 _ACP240 AntiCP 2.0 iACP-DRLF HemoPI Hemolytic2 PD_Hemolysis
standard
No
A 11-aa standard natural multi-activity (Antibacterial, Anticancer, Hemolysis, and other sources) peptide sequence curated from AntiBP3, Peptipedia, ACP740 _ACP240, and other sources, with an available 3D structural model.
Sequence
FLGWLFKWASK
Physicochemical Analysis
C72H99N15O13
RNDCEQHIMPTYV
LKFW
1382.67
10.60
2
0
7
+2
-5.13
0.382
80.00
Mammalian: 1.1 hour Yeast: 3 min E.coli: 2 min
11000
795.56
1
Residue Composition
number
1
A
0
R
0
N
0
D
0
C
0
E
0
Q
1
G
0
H
0
I
2
L
2
K
0
M
2
F
0
P
1
S
0
T
2
W
0
Y
0
V
Amino Acid Distribution
A: 1 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 1 H: 0 I: 0 L: 2 K: 2 M: 0 F: 2 P: 0 S: 1 T: 0 W: 2 Y: 0 V: 0
Chemical Descriptors
11
C72H99N15O13
1382.67
10.60
+2
-5.13
0.382
Evidence Records 11 records
Evidence 1 Activity

Activity

MIC
Antibacterial
25 µg/mL

Target

B. subtilis ATCC 6633

Source & Reference

NA

Other

active against Gram+ B. subtilis ATCC 6633 (MIC 25 ug/ml), M. luteus ATCC 10240 (MIC 12.5 ug/ml), S. aureus ATCC 6538p (MIC 25 ug/ml), S. epidermid
Evidence 2 Activity

Activity

MIC
Antibacterial
12.5 µg/mL

Target

M. luteus ATCC 10240

Source & Reference

NA

Other

active against Gram+ B. subtilis ATCC 6633 (MIC 25 ug/ml), M. luteus ATCC 10240 (MIC 12.5 ug/ml), S. aureus ATCC 6538p (MIC 25 ug/ml), S. epidermidis ATCC 12228 (MIC 50 ug/ml), Gram- E.
Evidence 3 Activity

Activity

MIC
Antibacterial
25 µg/mL

Target

Staphylococcus aureus ATCC 6538p

Source & Reference

NA

Other

gainst Gram+ B. subtilis ATCC 6633 (MIC 25 ug/ml), M. luteus ATCC 10240 (MIC 12.5 ug/ml), S. aureus ATCC 6538p (MIC 25 ug/ml), S. epidermidis ATCC 12228 (MIC 50 ug/ml), Gram- E. coli ATCC 25922 (MIC 50 ug/ml), S. dy
Evidence 4 Activity

Activity

MIC
Antibacterial
50 µg/mL

Target

Staphylococcus epidermidis ATCC 12228

Source & Reference

NA

Other

IC 25 ug/ml), M. luteus ATCC 10240 (MIC 12.5 ug/ml), S. aureus ATCC 6538p (MIC 25 ug/ml), S. epidermidis ATCC 12228 (MIC 50 ug/ml), Gram- E. coli ATCC 25922 (MIC 50 ug/ml), S. dysentariae ATCC 9752 (MIC 25 ug/ml), S.typh
Evidence 5 Activity

Activity

MIC
Antibacterial
50 µg/mL

Target

Escherichia coli ATCC 25922

Source & Reference

NA

Other

ml), S. aureus ATCC 6538p (MIC 25 ug/ml), S. epidermidis ATCC 12228 (MIC 50 ug/ml), Gram- E. coli ATCC 25922 (MIC 50 ug/ml), S. dysentariae ATCC 9752 (MIC 25 ug/ml), S.typhimorium ATCC 14028 (MIC 200 ug/ml), K. pn
Evidence 6 Activity

Activity

MIC
Antibacterial
25 µg/mL

Target

S. dysentariae ATCC 9752

Source & Reference

NA

Other

g/ml), S. epidermidis ATCC 12228 (MIC 50 ug/ml), Gram- E. coli ATCC 25922 (MIC 50 ug/ml), S. dysentariae ATCC 9752 (MIC 25 ug/ml), S.typhimorium ATCC 14028 (MIC 200 ug/ml), K. pneumonia ATCC 10031 (MIC 50 ug/ml), and P.
Evidence 7 Activity

Activity

MIC
Antibacterial
200 µg/mL

Target

S.typhimorium ATCC 14028

Source & Reference

NA

Other

ug/ml), Gram- E. coli ATCC 25922 (MIC 50 ug/ml), S. dysentariae ATCC 9752 (MIC 25 ug/ml), S.typhimorium ATCC 14028 (MIC 200 ug/ml), K. pneumonia ATCC 10031 (MIC 50 ug/ml), and P.aeruginosa ATCC 27853) (MIC 200 ug/ml).
Evidence 8 Activity

Activity

MIC
Antibacterial
50 µg/mL

Target

K. pneumonia ATCC 10031

Source & Reference

NA

Other

g/ml), S. dysentariae ATCC 9752 (MIC 25 ug/ml), S.typhimorium ATCC 14028 (MIC 200 ug/ml), K. pneumonia ATCC 10031 (MIC 50 ug/ml), and P.aeruginosa ATCC 27853) (MIC 200 ug/ml).
Evidence 9 Activity

Activity

100% Hemolysis
Toxicity
100 µg/mL
Hemolytic Cytotoxic
100% Hemolysis | 100 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5 | J Biol Chem | 2004
Evidence 10 Activity

Activity

5% Hemolysis
Toxicity
25 µg/mL
Hemolytic Cytotoxic
5% Hemolysis | 25 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Activity optimization of an undecapeptide analogue derived from a frog-skin antimicrobial peptide | Mol Cells | 2011
Evidence 11 Hemolysis

Source & Reference

HemoPI PD_Hemolysis
PD_Hemolysis